课题基金 / 基金详情

SEROTONIN N-ACETYLTRANSFERASE IN THE PINEAL GLAND

SEROTONIN N-ACETYLTRANSFERASE IN THE PINEAL GLAND
松果体中的血清素 N-乙酰转移酶
批准号:
3235695
负责人:
ARYAN Mangalam NAMBOODIRI
金额:
$12.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1990-12-31

项目摘要

项目成果

ARYAN Mangalam NAMBOODIRI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term objective of this research program is the understanding of the molecular mechanisms involved in the postsynaptic regulation of neuronal function, using the catecholamine mediated regulation of serotonin N- acetyltransferase (NAT) activity in the rat pineal gland as a model. This enzyme regulates the concentration of the putative pineal hormone, melatonin, in the circulation. The significance of this study derives from 1) the wide spread role of postsynaptic regulatory processes in both normal and disordered development and maintenance of nervous system functions, as well as 2) the demonstrated role of melatonin as a regulatory hormone in many vertebrates and the likelihood that it has similarly important, but incompletely documented, functions in man. In order to study the molecular mechanisms involved in the regulation of NAT itself and, indirectly, melatonin synthesis, the following immediate aims are proposed: 1) produce antibodies against NAT, 2) purify NAT to homogeneity, 3) determine whether the synthesis of NAT protein is increased when NAT activity is stimulated at night and 4) clone NAT cDNA if NAT protein synthesis is found to be regulated by light-dark cycles. Pineal NAT in the rat exhibits a circadian rhythm with 50-100 fold increase in activity at night in the dark. The increase in NAT activity is mediated by an adrenergic-camp mechanism involving both transcriptional and translational events. The PI has recently succeeded in purifying NAT from rat pineal gland and plans to continue his studies to understand the molecular mechanisms involved in NAT regulation. A three tiered approach for the production of antibodies of different quality/specificity will be proposed in order to permit the orderly investigation of the molecular biology of NAT regulation. The hypothesis that the nocturnal increase in NAT activity involves increased synthesis of NAT protein will be tested by determining the amount of NAT protein during day and night; this will be done by immunotitration of NAT activity. In addition, the rate of incorporation of radiolabelled amino acids into NAT protein will be determined during day and night with the aid of NAT antibodies. If the synthesis of NAT protein is found to be increased at night, then efforts will be focused on cloning NAT cDNA in order to subsequently study in detail the mechanisms involved in the regulation of expression of NAT gene. If it is not found to be the case, then subsequent efforts will be directed towards the analysis to possible post-translational mechanisms of NAT regulation with the aid of antibodies.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Differential regulation of arylamine and arylalkylamine N-acetyltransferases in human retinoblastoma (Y-79) cells.
人视网膜母细胞瘤 (Y-79) 细胞中芳基胺和芳基烷基胺 N-乙酰转移酶的差异调节。
DOI: 10.1016/0197-0186(93)90055-a
发表时间: 1993
期刊: Neurochemistry international
影响因子: 4.2
作者: [Gaudet,SJ, Hayden,BJ, Chader,GJ, Namboodiri,MA]
通讯作者: Namboodiri,MA
Regulation of melatonin synthesis in the ovine pineal gland.
绵羊松果体褪黑激素合成的调节。
DOI: 10.1007/978-1-4684-5952-4_12
发表时间: 1991
期刊: Advances in experimental medicine and biology
影响因子: --
作者: [Namboodiri,MA, Valivullah,HM, Moffett,JR]
通讯作者: Moffett,JR
Cloning and characterization of the epsilon and zeta isoforms of the 14-3-3 proteins.
14-3-3 蛋白的 epsilon 和 zeta 亚型的克隆和表征。
DOI: 10.1089/dna.1994.13.629
发表时间: 1994
期刊: DNA and cell biology
影响因子: 3.1
作者: [Roseboom,PH, Weller,JL, Babila,T, Aitken,A, Sellers,LA, Moffett,JR, Namboodiri,MA, Klein,DC]
通讯作者: Klein,DC
Acetate Supplementation as a therapeutic strategy for Canavan disease
Acetate Supplementation as a therapeutic strategy for Canavan disease
Intranasal CNS delivery of drugs against organophosphorous threat agents
Intranasal CNS delivery of drugs against organophosphorous threat agents
海外基金